HRT Financial’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,402
Closed -$68K 3603
2025
Q1
$68K Buy
+11,402
New +$69.7K ﹤0.01% 2206
2024
Q2
Sell
-65,206
Closed -$769K 3191
2024
Q1
$769K Buy
+65,206
New +$753K ﹤0.01% 1017
2023
Q2
Sell
-2,251
Closed -$11K 3359
2023
Q1
$11K Buy
+2,251
New +$14.2K ﹤0.01% 2242
2022
Q4
Sell
-2,435
Closed -$24K 3224
2022
Q3
$24K Buy
+2,435
New +$34K ﹤0.01% 2477
2022
Q2
Sell
-1,494
Closed -$25K 3805
2022
Q1
$25K Sell
1,494
-17,482
-92% -$301K ﹤0.01% 2809
2021
Q4
$466K Buy
18,976
+9,020
+91% +$285K ﹤0.01% 1943
2021
Q3
$367K Buy
+9,956
New +$366K ﹤0.01% 2272
2020
Q3
Sell
-9,915
Closed -$204K 2403
2020
Q2
$204K Buy
+9,915
New +$262K 0.01% 1154
2019
Q4
Sell
-1,272
Closed -$18K 1684
2019
Q3
$18K Buy
+1,272
New +$20.7K ﹤0.01% 1342
2019
Q2
Sell
-4,611
Closed -$163K 930
2019
Q1
$163K Buy
+4,611
New +$182K 0.03% 413
2018
Q4
Sell
-1,260
Closed -$109K 767
2018
Q3
$109K Buy
+1,260
New +$125K 0.02% 359

Other funds holding VSTM

HRT Financial's VSTM Position: Q2 2025 in Review

HRT Financial sold out of Verastem (VSTM) in Q2 2025, closing a stake of 11,402 shares — an estimated $68K sold.

HRT Financial first reported a position in VSTM in Q3 2018 and held it in 11 quarters. The position peaked at $769K in Q1 2024. 110 funds tracked by Wall St. Rank hold VSTM as of Q2 2025.

  • HRT Financial reported no remaining Verastem position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 11,402 Verastem shares in Q2 2025, an estimated $68K.
  • HRT Financial first reported a position in Verastem in Q3 2018 and held it in 11 quarters.
  • HRT Financial's Verastem position peaked at $769K in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Verastem as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.